We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Model Predicts ICU mortality in Heart Failure Patients

By HospiMedica International staff writers
Posted on 02 Jul 2025

Currently, heart failure has emerged as a significant complication during the later stages of various cardiovascular disorders. More...

In the Intensive Care Unit (ICU), patients with heart failure often experience more severe and complicated conditions. This condition is commonly linked to multiple comorbidities, such as hypertension, coronary artery disease, chronic obstructive pulmonary disease, and chronic kidney disease. Consequently, ICU physicians must handle a wide range of clinical data, including patients’ medical histories, lab reports, imaging studies, prescribed medications, and continuous monitoring of vital signs. The sheer volume and complexity of this data make it difficult to quickly identify essential clinical information, thereby heightening the risk of misdiagnosis or delays in initiating treatment.

To overcome this issue, the healthcare sector has increasingly turned to artificial intelligence (AI) and big data technologies to support ICU physicians. While several predictive tools have been created to assess mortality risk in heart failure patients, these systems often depend on a combination of numerous variables and complex scoring frameworks. This poses a challenge since critically ill patients may not be suitable for extensive testing, and many smaller hospitals lack the diagnostic resources to support such assessments. In contrast, blood tests are simpler to perform and provide a comprehensive overview of the patient’s overall health. Now, an AI-driven model has demonstrated the ability to accurately forecast mortality risk in ICU patients with heart failure using only blood test data and vital signs.

A research team at Lanzhou University (Gansu, China) developed and trained nine AI models using 5,383 patient cases from the eICU database, along with an additional 530 cases from the MIMIC-IV database for external validation. These cases involved patients diagnosed primarily with heart failure, and the dataset covered a range of variables including age, blood oxygen saturation, white and red blood cell counts, platelet levels, hemoglobin, electrolyte levels, lactate, glucose, and other physiological and biochemical markers obtained during ICU admission. To improve the models’ reliability and ensure their broader applicability, all data underwent thorough preprocessing and standardization before model training.

The team applied several machine learning algorithms and used cross-validation to test the performance of the models, with the F1-score as the main evaluation metric. Of the nine models developed, the Multi-Layer Perceptron (MLP) achieved the best results, attaining the highest recall score of 0.64, which means it was most effective in identifying true positive cases and reducing missed diagnoses. It also recorded the highest performance scores in both the Macro F1 (0.74) and Weighted F1 (0.88) categories, indicating a strong balance across multiple classification metrics. The strong F1 results of the MLP model underscore its potential for clinical use in managing critically ill heart failure patients.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Electrically Operated Patient Lifter
SVL 205
New
Short Phlebotomy Cart
MSWA-3469-WHT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.